C, J., S, A., C, H., JM, S., & C, S. (2026). Clinical impact of bacterial heteroresistance. JAC-antimicrobial resistance, 8(3), dlag075. https://doi.org/10.1093/jacamr/dlag075
Chicago Style (17th ed.) CitationC, Joyce, Anwar S, Hind C, Sutton JM, and Sergaki C. "Clinical Impact of Bacterial Heteroresistance." JAC-antimicrobial Resistance 8, no. 3 (2026): dlag075. https://doi.org/10.1093/jacamr/dlag075.
MLA (9th ed.) CitationC, Joyce, et al. "Clinical Impact of Bacterial Heteroresistance." JAC-antimicrobial Resistance, vol. 8, no. 3, 2026, p. dlag075, https://doi.org/10.1093/jacamr/dlag075.
Warning: These citations may not always be 100% accurate.